• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,066.38 257.90
( 0.34%)
Global Indices
Nasdaq
52,022.73 330.70
(0.64%)
Dow Jones
7,531.82 -43.47
(-0.57%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.63 -0.29
(-0.31%)
EUR-INR
109.79 -0.04
(-0.03%)
GBP-INR
127.09 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
143.94
432036.25
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

fortis healthcare ltd
Saurashtra Cement consolidated net profit declines 42.78% in the March 2026 quarter
May 12,2026
Net profit of Saurashtra Cement declined 42.78% to Rs 18.83 crore in the quarter ended March 2026 as against Rs 32.91 crore during the previous quarter ended March 2025. Sales declined 6.57% to Rs 446.65 crore in the quarter ended March 2026 as against Rs 478.05 crore during the previous quarter ended March 2025.

For the full year,net profit rose 106.59% to Rs 14.42 crore in the year ended March 2026 as against Rs 6.98 crore during the previous year ended March 2025. Sales rose 8.35% to Rs 1666.04 crore in the year ended March 2026 as against Rs 1537.62 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales446.65478.05 -7 1666.041537.62 8
OPM %5.9211.03 -3.152.85 -
PBDT28.4254.99 -48 60.9247.37 29
PBT16.2943.88 -63 16.695.09 228
NP18.8332.91 -43 14.426.98 107